Lexeo Therapeutics, Inc. (LXEO) Balance Sheet
As of 2026-06-30 (10-Q), Lexeo Therapeutics, Inc. (LXEO) reported total assets of $254.9M, total liabilities of $19.8M and shareholders' equity of $235.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $92.8M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LXEOLexeo Therapeutics, Inc.Follow LXEO — free
—
Price chart with a free account
- Market cap
- 229.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|
| Cash and equivalents | 121.5 | 35.0 | 63.0 | 92.8 | |
| Short-term investments | — | 86.5 | 118.8 | 118.9 | |
| Current assets | 124.3 | 126.1 | 188.4 | 217.9 | |
| Total assets | 139.8 | 146.9 | 268.7 | 254.9 | |
| Current liabilities | 17.2 | 22.8 | 16.8 | 15.7 | |
| Total liabilities | 26.3 | 30.1 | 22.0 | 19.8 | |
| Shareholders' equity | 113.5 | 116.8 | 246.7 | 235.1 |
USD millions · SEC XBRL
Lexeo Therapeutics, Inc. — questions
- How much cash does Lexeo Therapeutics, Inc. have?
- $92.8M in cash and cash equivalents as of 2026-06-30.
- What are Lexeo Therapeutics, Inc.'s total assets?
- $254.9M as of 2026-06-30.
- What is Lexeo Therapeutics, Inc.'s shareholders' equity?
- $235.1M as of 2026-06-30.
Every figure on this page comes from Lexeo Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.